Evergreen Theragnostics is a series c plus startup. 1 investor tracked. Status: possibledead.
Evergreen Theragnostics is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Evergreen Theragnostics is a clinical-stage radiopharmaceutical company focused on improving options for cancer patients through theragnostic radiopharmaceuticals. The company operates as a Contract Development and Manufacturing Organization (CDMO), offering services in the development, manufacturing, and commercialization of radiopharmaceuticals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.